首页 | 本学科首页   官方微博 | 高级检索  
     

The Drug Sensitivity of Cyclosporine A Combined with Antineoplastic Drugs in Retinoblastoma in Vitro
引用本文:Wanli Liu,Zhongyao Wu Zhongshan Ophthalmic Center,Sun Yat-sen University,Guangzhou 510060,China. The Drug Sensitivity of Cyclosporine A Combined with Antineoplastic Drugs in Retinoblastoma in Vitro[J]. 眼科学报, 2005, 21(1): 62-67
作者姓名:Wanli Liu  Zhongyao Wu Zhongshan Ophthalmic Center  Sun Yat-sen University  Guangzhou 510060  China
作者单位:Wanli Liu,Zhongyao Wu Zhongshan Ophthalmic Center,Sun Yat-sen University,Guangzhou 510060,China
摘    要:Purpose: To study cyelosporine A inhibition on the fresh retinoblastoma cells in vitro and increasing the drug sensitivity after combined with different antineoplastic drugs. Methods : To study the growth curve of cyelosporine A on 27 samples of primary retinoblastoma cells by MTT assay and to study the change of the drug sensitivity by cyelosporine A combined with seven antineoplastic drugs. Results: The average IC50 of cyelosporine A on the 27 retinoblastoma cells is 67.81μg/ ml and the average inhibitive rate of these samples is 26.1% when cyelosporine A is in the concentration of 2μg/ml. The inhibitive rates all got improved after the seven antineoplastic drugs combined with cyelosporine A and the increasing average inhibitive rate is more than 5. Conclusion: Cyelosporine A can inhibit retinoblastoma cells in vitro and its inhibitive effect is dose dependent. Moreover it can enhance the inhibition of multiple antineoplastic drugs on retinoblastoma cells. Eye Science 2005;21;62-66.

关 键 词:眼肿瘤  抗肿瘤药物  环孢霉素A  药物治疗

The Drug Sensitivity of Cyclosporine A Combined with Antineoplastic Drugs in Retinoblastoma in Vitro
Wanli Liu,Zhongyao Wu. The Drug Sensitivity of Cyclosporine A Combined with Antineoplastic Drugs in Retinoblastoma in Vitro[J]. Eye science, 2005, 21(1): 62-67
Authors:Wanli Liu  Zhongyao Wu
Affiliation:Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
Abstract:PURPOSE: To study cyclosporine A inhibition on the fresh retinoblastoma cells in vitro and increasing the drug sensitivity after combined with different antineoplastic drugs. METHODS: To study the growth curve of cyclosporine A on 27 samples of primary retinoblastoma cells by MTT assay and to study the change of the drug sensitivity by cyclosporine A combined with seven antineoplastic drugs. RESULTS: The average IC50 of cyclosporine A on the 27 retinoblastoma cells is 67.81microg/ ml and the average inhibitive rate of these samples is 26.1% when cyclosporine A is in the concentration of 2microg/ml. The inhibitive rates all got improved after the seven antineoplastic drugs combined with cyclosporine A and the increasing average inhibitive rate is more than 5. CONCLUSION: Cyclosporine A can inhibit retinoblastoma cells in vitro and its inhibitive effect is dose dependent. Moreover it can enhance the inhibition of multiple antineoplastic drugs on retinoblastoma cells.
Keywords:retinoblastoma  cyclosporine A  MTT assay
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号